Lisi S.A.
Lisi S.A. (LSIIF) Financial Performance & Income Statement Overview
Analyze Lisi S.A. (LSIIF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Lisi S.A. (LSIIF) Income Statement & Financial Overview
View the income breakdown for Lisi S.A. LSIIF across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $890.46M | $929.63M | $808.68M | $821.76M |
| Cost of Revenue | $869.70M | $466.83M | $785.84M | $805.70M |
| Gross Profit | $20.76M | $462.80M | $22.84M | $16.07M |
| Gross Profit Ratio | $0.02 | $0.50 | $0.03 | $0.02 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $347.71M | $0.00 | $312.41M |
| Operating Expenses | -$40.26M | $411.88M | -$30.90M | -$20.88M |
| Total Costs & Expenses | -$829.44M | $878.70M | $754.94M | $784.82M |
| Interest Income | $2.37M | $1.74M | $1.63M | $25000.00 |
| Interest Expense | $16.56M | $14.65M | $40.64M | $4.96M |
| Depreciation & Amortization | $52.08M | $43.63M | $50.91M | $49.99M |
| EBITDA | $102.12M | $97.64M | $104.65M | $80.45M |
| EBITDA Ratio | $0.11 | $0.11 | $0.13 | $0.11 |
| Operating Income | $61.02M | $50.93M | $53.74M | $36.95M |
| Operating Income Ratio | $0.07 | $0.05 | $0.07 | $0.04 |
| Other Income/Expenses (Net) | -$27.55M | -$8.36M | -$18.48M | -$11.45M |
| Income Before Tax | $33.47M | $42.56M | $35.26M | $25.50M |
| Income Before Tax Ratio | $0.04 | $0.05 | $0.04 | $0.03 |
| Income Tax Expense | $9.25M | $11.36M | $11.43M | $12.65M |
| Net Income | $24.43M | $31.57M | $24.07M | $13.46M |
| Net Income Ratio | $0.03 | $0.03 | $0.03 | $0.02 |
| EPS | $0.54 | $0.69 | $0.52 | $0.30 |
| Diluted EPS | $0.52 | $0.68 | $0.52 | $0.29 |
| Weighted Avg Shares Outstanding | $45.56M | $45.56M | $46.09M | $45.48M |
| Weighted Avg Shares Outstanding (Diluted) | $46.70M | $46.35M | $46.09M | $46.09M |
The company's financials show resilient growth, with revenue advancing from $821.76M in Q2 2023 to $890.46M in Q4 2024. Gross profit remained healthy with margins at 2% in Q4 2024 compared to 2% in Q2 2023. Operating income hit $61.02M last quarter, sustaining a consistent 7% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $102.12M. Net income dropped to $24.43M, while earnings per share reached $0.54. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan